Research published in Journal of the American Chemical Society highlights potential of HIF Inhibition as a therapeutic approach for cancers

Research led by Curve CSO Professor Ali Tavassoli’s laboratory at University of SouthamptonLandmark paper on dual HIF-1 and HIF-2 inhibitor that works by inhibiting the interaction of both HIF-1α and HIF-2α with HIF-1β Southampton, UK, 26 March 2024 - Curve Therapeutics (“Curve&rdqu...

Related Keywords

United Kingdom ,United States ,American ,Soran Mohammed ,Jamesw Easton ,Reecem Gardner ,Steven Turner ,Ali Tavassoli ,Jonathanw Essex ,Garry Pairaudeau ,Cyrielle Doigneaux ,Journal Of The American Chemical Society ,University Of Southampton ,American Chemical Society ,Cyclic Peptide Inhibitors ,Hypoxia Inducible Factors ,Disrupt Hypoxia Related Signalling ,Cancer Cell ,Chief Scientific Officer ,Professor Ali Tavassoli ,Curve Therapeutics ,Disrupt Hypoxia Response Signaling ,Cancer Cells ,